Ann: Alterity to Present at the Janney Healthcare Conference, page-3

PBT2 & PBT434 are drugs that have & do offer so much promise but unfortunately for LT holders the management & the SP have ultimately become a 'broken promise.' As SH we have been thrown under the ATH bus and deteriorated to a 'mushroom status,'.....kept in the dark and fed on bullsh#t. I hope they do succeed for sufferers of these terrible neurological diseases and good luck to new holders jumping on the ATH train.....I mean good luck because GK is still at the helm of the ship......and I'm not sure really anything will change. LT have endured dilution and SP erosion for years now without any real care or concern from management. I still hold......purely in hope....I won't be buying any more shares to rationalise my 'break even' price because I have no confidence that anything has changed other than the company name. GLTAH